Cargando…
Roadmap to improve regional care for patients with severe asthma
Autores principales: | van der Valk, J. P. M., Kappen, J. H., van Campen, J. S. J. A., Epping, G., Retera, J. M. A. M., de Bondt, D., Suwandy, F., Tolboom, M., in 't Veen, J. C. C. M., Braunstahl, G. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805686/ https://www.ncbi.nlm.nih.gov/pubmed/34962718 http://dx.doi.org/10.1002/clt2.12080 |
Ejemplares similares
-
Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
por: van der Veer, Tjeerd, et al.
Publicado: (2021) -
STOP: an open label crossover trial to study ICS withdrawal in patients with a combination of obesity and low-inflammatory asthma and evaluate its effect on asthma control and quality of life
por: Witte, Jan A., et al.
Publicado: (2022) -
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017) -
Afwijkingen van het respiratoire systeem
por: Braunstahl, G. J., et al.
Publicado: (2015) -
Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial
por: de Boer, Geertje M., et al.
Publicado: (2021)